Complement-opsonized HIV: the free rider on its way to infection
- PMID: 15488605
- DOI: 10.1016/j.molimm.2004.06.024
Complement-opsonized HIV: the free rider on its way to infection
Abstract
The complement system (C) is one of the main humoral components of innate immunity. Three major tasks of C against invading pathogens are: (i) lysis of pathogens by the formation of the membrane attack complex (MAC); (ii) opsonization of pathogens with complement fragments to favor phagocytosis; and (iii) attraction of inflammatory cells by chemotaxis. Like other particles, HIV activates C and becomes opsonized. To escape complement-mediated lysis, HIV has adopted various properties, which include the acquisition of HIV-associated molecules (HAMs) belonging to the family of complement regulators, such as CD46, CD55, CD59, and the interaction with humoral regulatory factors like factor H (fH). Opsonized virus may bind to complement receptor positive cells to infect them more efficiently or to remain bound on the surface of such cells. In the latter case HIV can be transmitted to cells susceptible for infection. This review discusses several aspects of C-HIV interactions and provides a model for the dynamics of this process.
Similar articles
-
C-type lectin-independent interaction of complement opsonized HIV with monocyte-derived dendritic cells.Eur J Immunol. 2005 Sep;35(9):2691-8. doi: 10.1002/eji.200425940. Eur J Immunol. 2005. PMID: 16094691
-
Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo.J Immunol. 1996 Aug 15;157(4):1791-8. J Immunol. 1996. PMID: 8759769
-
HIV and human complement: inefficient virolysis and effective adherence.Immunol Lett. 2005 Mar 15;97(2):209-14. doi: 10.1016/j.imlet.2004.11.007. Epub 2004 Nov 28. Immunol Lett. 2005. PMID: 15752560 Review.
-
Complement regulator loss on apoptotic neuronal cells causes increased complement activation and promotes both phagocytosis and cell lysis.Mol Immunol. 2006 May;43(12):1953-64. doi: 10.1016/j.molimm.2005.11.015. Epub 2006 Jan 10. Mol Immunol. 2006. PMID: 16406094
-
T-cell regulation: with complements from innate immunity.Nat Rev Immunol. 2007 Jan;7(1):9-18. doi: 10.1038/nri1994. Epub 2006 Dec 1. Nat Rev Immunol. 2007. PMID: 17170757 Review.
Cited by
-
A novel approach to inhibit HIV-1 infection and enhance lysis of HIV by a targeted activator of complement.Virol J. 2009 Aug 12;6:123. doi: 10.1186/1743-422X-6-123. Virol J. 2009. PMID: 19671191 Free PMC article.
-
Lysis of human immunodeficiency virus type 1 by a specific secreted human phospholipase A2.J Virol. 2007 Feb;81(3):1444-50. doi: 10.1128/JVI.01790-06. Epub 2006 Nov 8. J Virol. 2007. PMID: 17093191 Free PMC article.
-
Investigation of interaction of vaccinia virus complement control protein and curcumin with complement components c3 and c3b using quartz crystal microbalance with dissipation monitoring technology.Open Biochem J. 2010 Jan 27;4:9-21. doi: 10.2174/1874091X01004010009. Open Biochem J. 2010. PMID: 20224684 Free PMC article.
-
Aspects of the Complement System in New Era of Xenotransplantation.Front Immunol. 2022 Apr 14;13:860165. doi: 10.3389/fimmu.2022.860165. eCollection 2022. Front Immunol. 2022. PMID: 35493484 Free PMC article. Review.
-
Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization.Front Immunol. 2019 Dec 18;10:2968. doi: 10.3389/fimmu.2019.02968. eCollection 2019. Front Immunol. 2019. PMID: 31921207 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous